drugset / Trial / NCT07781631
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.
Timeline
- Start
- 2026-09-10
- Primary completion
- 2026-12-14
- Completion
- 2026-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | — | — |
| Subject | Verducatib | Unknown | — | — |
Indications
No indication recorded.